Savas, Peter
Salgado, Roberto
Denkert, Carsten
Sotiriou, Christos
Darcy, Phillip K.
Smyth, Mark J.
Loi, Sherene
Article History
First Online: 15 December 2015
Competing interests
: S.L. receives research support from Merck, Novartis, Pfizer and Roche-Genentech, and co-chairs the PANACEA and BOSTON-II studies. M.J.S. has received research support from Bristol-Myers Squibb, and is a consultant for Amgen, F-star and Kymab. C.D. is the cofounder and shareholder of Sividon Diagnostics, Cologne, Germany. The other authors declare no competing interests.